Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia
出版年份 2019 全文链接
标题
Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-08-12
DOI
10.1038/s41598-019-48204-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Blood transfusion therapy for β‐thalassemia major and hemoglobin E β‐thalassemia: Adequacy, trends, and determinants in Sri Lanka
- (2019) Sachith Mettananda et al. PEDIATRIC BLOOD & CANCER
- A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?
- (2018) Maria Domenica Cappellini et al. BLOOD REVIEWS
- Phenotypic and molecular characterization of a serum-free miniature erythroid differentiation system suitable for high-throughput screening and single-cell assays
- (2018) Sachith Mettananda et al. EXPERIMENTAL HEMATOLOGY
- Interaction of Transfusion and Iron Chelation in Thalassemias
- (2018) John B. Porter et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Molecular Basis and Genetic Modifiers of Thalassemia
- (2018) Sachith Mettananda et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Thalassaemia
- (2018) Ali T Taher et al. LANCET
- Anaemia among females in child-bearing age: Relative contributions, effects and interactions of α- and β-thalassaemia
- (2018) Sachith Mettananda et al. PLoS One
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
- (2017) Sachith Mettananda et al. Nature Communications
- A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma
- (2017) Priscila H. Goncalves et al. Oncotarget
- Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia
- (2016) Sachith Mettananda et al. HAEMATOLOGICA
- Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia
- (2016) Sachith Mettananda et al. HAEMATOLOGICA
- Understanding α-globin gene regulation and implications for the treatment of β-thalassemia
- (2015) Sachith Mettananda et al. Annals of the New York Academy of Sciences
- -Globin as a molecular target in the treatment of -thalassemia
- (2015) S. Mettananda et al. BLOOD
- Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea
- (2015) M. M. Okam et al. BLOOD
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- Anemia: progress in molecular mechanisms and therapies
- (2015) Vijay G Sankaran et al. NATURE MEDICINE
- Targeting histone lysine demethylases — Progress, challenges, and the future
- (2014) Cyrille C. Thinnes et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Modulation of gamma globin genes expression by histone deacetylase inhibitors: anin vitrostudy
- (2014) Luisa Ronzoni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic reprogramming induces the expansion of cord blood stem cells
- (2014) Pratima Chaurasia et al. JOURNAL OF CLINICAL INVESTIGATION
- Fetal Globin Gene Repressors as Drug Targets for Molecular Therapies To Treat the -Globinopathies
- (2014) M. Suzuki et al. MOLECULAR AND CELLULAR BIOLOGY
- Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor
- (2013) Marian Iwamoto et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Switch from Fetal to Adult Hemoglobin
- (2013) V. G. Sankaran et al. Cold Spring Harbor Perspectives in Medicine
- Reawakening fetal hemoglobin: prospects for new therapies for the -globin disorders
- (2012) D. E. Bauer et al. BLOOD
- The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia
- (2012) Swee Lay Thein BLOOD REVIEWS
- The challenge of haemoglobinopathies in resource-poor countries
- (2011) David J. Weatherall BRITISH JOURNAL OF HAEMATOLOGY
- Thalassaemia
- (2011) Douglas R Higgs et al. LANCET
- The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice
- (2010) R. P. Hebbel et al. BLOOD
- The inherited diseases of hemoglobin are an emerging global health burden
- (2010) D. J. Weatherall BLOOD
- Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
- (2010) James E. Bradner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases⊥
- (2008) Nathan R. Rose et al. JOURNAL OF MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now